Adjuvants and Vaccine Formulation

M3

Course Goals 

The course provides an overview of State-of-the-art adjuvant systems and addresses the preclinical and clinical development of adjuvanted vaccines.

Timeline 

Application Deadline:
15 of December 2021

Course Dates:
21-24 March 2022 (4 days)

Organiser

Vaccine Formulation Institute (VFI), Geneva, Switzerland


Participant Nr.: 10

Contact

Course content

Combination of lectures, discussion rounds, and group work on thematic case studies. Topics: Adjuvant systems, such as aluminum salts, oil-in-water emulsions, water-in-Oil emulsions, liposomes, PLGA particles, virosomes, QS21, TLR ligands) and preclinical and clinical development of adjuvanted vaccines.

Learning Outcomes

Good understanding of the different adjuvant systems and of the challenges of preclinical and clinical development of adjuvanted vaccines.

Who should apply

Scientists and professionals involved in research and development of vaccines who are working with – or planning to work with – adjuvants.

Minimal requirements

Applicants should have a BSc or MSc, or have demonstrable vaccine-related research experience.

Accommodation

Accommodation will be provided. Travel Costs are not included.

Comments

The course will be organized in collaboration with ENOVA, the European Network of Vaccine Adjuvants. ENOVA will sponsor 10 additional participants, selected via the separate ENOVA call for applications.

*Due to COVID19 related delays call and training modules' schedule may be subject to change.

Weblink

NA

How to apply>>

Kindly note that not all courses are open for application submission, check open calls to know which for which courses you can apply for at the moment.


Be the first to know about the upcoming application calls, follow European Vaccine Initiative on Twitter and LinkedIn or subscribe to TRANSVAC Newsletter